Colistin Resistance in Enterobacteriaceae: Current Trends in Africa

Background on Colistin Resistance in Enterobacteriaceae

Colistin resistance among Enterobacteriaceae has emerged as a significant global health concern, particularly in the context of increasing antimicrobial resistance. Colistin, a last-resort antibiotic, is crucial in treating infections caused by multidrug-resistant (MDR) bacteria, including those resistant to carbapenems. The rise of colistin resistance is attributed to various factors, including the inappropriate use of colistin in both human medicine and agriculture, leading to the dissemination of plasmid-mediated colistin resistance genes. Given the limited therapeutic options available against resistant strains, understanding the dynamics of colistin resistance in Enterobacteriaceae is essential for effective public health interventions.

Research shows that the prevalence of colistin resistance varies significantly across regions, with developing countries particularly affected due to factors such as inadequate healthcare infrastructure and the uncontrolled use of antibiotics. In Africa, where healthcare resources are limited, the emergence of colistin-resistant Enterobacteriaceae poses a severe threat, complicating treatment protocols and increasing morbidity and mortality rates associated with bacterial infections.

Methods for Assessing Colistin Resistance in Africa

The assessment of colistin resistance in Enterobacteriaceae in Africa predominantly relies on systematic reviews and meta-analyses of clinical samples. A systematic search was conducted across major databases, including PubMed, Scopus, and ScienceDirect, to identify relevant studies assessing colistin resistance. Inclusion criteria focused on studies that reported prevalence data of colistin-resistant Enterobacteriaceae isolated from clinical specimens.

In total, 41 studies involving a cumulative analysis of 9,636 Enterobacteriaceae isolates were reviewed. The methodological rigor of these studies varied, with many employing standard microbiological techniques for susceptibility testing, including disk diffusion and broth microdilution methods. The studies were assessed for heterogeneity using the I² statistic, and publication bias was evaluated through Egger’s test.

Overview of Pooled Prevalence Rates of Colistin Resistance

The systematic review revealed a pooled prevalence of colistin resistance among Enterobacteriaceae of 26.74% (95% CI: 16.68–36.80). Notably, there was significant variability in resistance rates among different countries, highlighting the regional differences in antimicrobial stewardship and infection control practices. The resistance rates ranged from a low of 0.5% in Djibouti to as high as 50.95% in South Africa, with species-specific resistance profiles indicating that Klebsiella pneumoniae exhibited a resistance rate of 28.8% (95% CI: 16.64%-41.05%) and Escherichia coli at 24%.

These findings underscore the urgency of addressing the factors contributing to colistin resistance in Africa, such as enhancing surveillance systems, implementing effective infection control measures, and promoting rational use of antibiotics in both human and veterinary medicine.

Species-Specific Resistance Profiles of Enterobacteriaceae

Species-specific resistance profiles are critical in understanding the landscape of colistin resistance. Among the Enterobacteriaceae, Klebsiella pneumoniae and Escherichia coli are two of the most clinically significant pathogens. The prevalence rates indicate that K. pneumoniae shows a higher frequency of colistin resistance compared to E. coli. This disparity raises concerns regarding treatment options for infections caused by these organisms, particularly in the African context where healthcare resources are often limited.

Other species of Enterobacteriaceae, such as Enterobacter cloacae and Citrobacter freundii, have also been noted for their resistance profiles, albeit with varying prevalence rates. The rising incidence of colistin-resistant strains necessitates the development of tailored treatment strategies and the implementation of robust infection control measures in healthcare settings.

Implications of Colistin Resistance on Public Health in Africa

The implications of colistin resistance in Enterobacteriaceae extend beyond individual patient outcomes, impacting public health on a broader scale. The increasing prevalence of MDR and colistin-resistant pathogens poses significant challenges to healthcare systems, particularly in resource-limited settings. The rise in such infections can lead to prolonged hospital stays, increased healthcare costs, and higher mortality rates.

Moreover, the public health implications include the potential for outbreaks of infections caused by resistant strains, which can strain already overburdened healthcare facilities. The need for effective antimicrobial stewardship programs and enhanced surveillance of antimicrobial resistance is paramount for controlling the spread of colistin-resistant Enterobacteriaceae.

Strategies to Combat Colistin Resistance in Healthcare Settings

To effectively combat colistin resistance in Enterobacteriaceae, a multifaceted approach is required. Key strategies include:

1. Antimicrobial Stewardship: Implementing robust antimicrobial stewardship programs in healthcare facilities to promote the appropriate use of colistin and other antibiotics.

2. Surveillance: Enhancing surveillance systems to monitor trends in antimicrobial resistance and identify outbreaks of resistant strains.

3. Infection Control: Strengthening infection prevention and control measures in healthcare settings to limit the spread of resistant pathogens.

4. Education and Training: Providing education and training for healthcare professionals on the implications of antimicrobial resistance and the importance of rational antibiotic use.

5. Research and Development: Supporting research initiatives aimed at developing new antibiotics and alternative therapies to treat infections caused by resistant strains.

By implementing these strategies, healthcare systems in Africa can better manage the threat posed by colistin-resistant Enterobacteriaceae and improve patient outcomes.

Frequently Asked Questions (FAQ)

What is colistin resistance?

Colistin resistance refers to the ability of bacteria, particularly Enterobacteriaceae, to survive and grow in the presence of colistin, an antibiotic typically used as a last resort for treating multidrug-resistant infections.

Why is colistin important?

Colistin is considered a last-resort antibiotic for treating infections caused by multidrug-resistant bacteria, particularly those resistant to more commonly used antibiotics.

How is colistin resistance assessed?

Colistin resistance is assessed through laboratory techniques such as disk diffusion and broth microdilution methods, which measure the growth of bacteria in the presence of the antibiotic.

What are the implications of colistin resistance?

The implications include increased morbidity and mortality from infections, prolonged hospital stays, and the potential for outbreaks of resistant strains, which can strain healthcare systems.

What strategies are being implemented to combat colistin resistance?

Strategies include antimicrobial stewardship programs, enhanced surveillance, infection control measures, education for healthcare professionals, and support for research and development of new antibiotics.

References

1. Gashaw, Y., Asmare, Z., Tigabie, M., Sisay, A., Getatachew, E., Tadesse, S., Bitew, G., Ashagre, A., Misganaw, T., Gashaw, M., Kassahun, W., Dejazimach, Z., Jemal, A., Gedfie, S., Kumie, G., Nigatie, M., Abebe, W., Kidie, A., Abate, B. (2025). Prevalence of colistin-resistant Enterobacteriaceae isolated from clinical samples in Africa: a systematic review and meta-analysis. BMC Infect Dis. https://doi.org/10.1186/s12879-025-10826-5

2. Clinical results of combined aortic valve-sparing root replacement and mitral valve repair. Clinical results of combined aortic valve-sparing root replacement and mitral valve repair. https://pubmed.ncbi.nlm.nih.gov/11955238/

3. Impact of diaphragm paralysis and its surgical interventions on outcomes after the staged Fontan procedure. Impact of diaphragm paralysis and its surgical interventions on outcomes after the staged Fontan procedure. https://pubmed.ncbi.nlm.nih.gov/11955237/

4. A probabilistic modeling framework for genomic networks incorporating sample heterogeneity. A probabilistic modeling framework for genomic networks incorporating sample heterogeneity. https://doi.org/10.1016/j.crmeth.2025.100984

5. Prevention of Intraoperative Acquired Pressure Injury in Patients With Head and Neck Cancer and Its Effect on Skin Microclimate: A Single‐Blind Randomised Controlled Trial. Prevention of Intraoperative Acquired Pressure Injury in Patients With Head and Neck Cancer and Its Effect on Skin Microclimate: A Single‐Blind Randomised Controlled Trial. https://pubmed.ncbi.nlm.nih.gov/11955250/

6. Radiomics features outperform standard radiological measurements in detecting femoroacetabular impingement on three-dimensional magnetic resonance imaging. Radiomics features outperform standard radiological measurements in detecting femoroacetabular impingement on three-dimensional magnetic resonance imaging. https://pubmed.ncbi.nlm.nih.gov/11955221/

7. Preoperative Optical Coherence Tomography Markers and Their Significance in the Treatment of Macular Holes Using the Inverted Internal Limiting Membrane Technique. Preoperative Optical Coherence Tomography Markers and Their Significance in the Treatment of Macular Holes Using the Inverted Internal Limiting Membrane Technique. https://doi.org/10.7759/cureus.79837

8. Dichorionic Diamniotic Twin Reduction Surviving the Odds: A Case Report. Dichorionic Diamniotic Twin Reduction Surviving the Odds: A Case Report. https://doi.org/10.7759/cureus.79842

9. A Longitudinal Study of Preterm Infants at 12 and 30 Months: Links Among Object Interactions, Joint Engagement, and Cognitive Development. A Longitudinal Study of Preterm Infants at 12 and 30 Months: Links Among Object Interactions, Joint Engagement, and Cognitive Development. https://pubmed.ncbi.nlm.nih.gov/11955220/

10. Dermatomyositis as a Paraneoplastic Syndrome in Cases of Aggressive Cervical Cancer. Dermatomyositis as a Paraneoplastic Syndrome in Cases of Aggressive Cervical Cancer. https://doi.org/10.7759/cureus.79838

11. Assessing the Impact: The Damage Index for Antiphospholipid Syndrome in the Context of Other Autoimmune Diseases and Cardiovascular Risk Factors. Assessing the Impact: The Damage Index for Antiphospholipid Syndrome in the Context of Other Autoimmune Diseases and Cardiovascular Risk Factors. https://doi.org/10.7759/cureus.79849

12. Digenic variant interpretation with hypothesis-driven explainable AI. Digenic variant interpretation with hypothesis-driven explainable AI. https://pubmed.ncbi.nlm.nih.gov/11954523/

13. An orally administered gold nanocluster with ROS scavenging for inflammatory bowel disease treatment. An orally administered gold nanocluster with ROS scavenging for inflammatory bowel disease treatment. https://doi.org/10.1016/j.fmre.2022.07.002

14. Impact of an Extracurricular Research Course on Medical Students: A Quasi-Experimental Study. Impact of an Extracurricular Research Course on Medical Students: A Quasi-Experimental Study. https://doi.org/10.2147/AMEP.S509323

15. Autism Spectrum Disorder and Dietary Intake of Vitamin E. Autism Spectrum Disorder and Dietary Intake of Vitamin E. https://pubmed.ncbi.nlm.nih.gov/11955277/

16. Critical biomarkers for responsive deep brain stimulation and responsive focal cortex stimulation in epilepsy field. Critical biomarkers for responsive deep brain stimulation and responsive focal cortex stimulation in epilepsy field. https://doi.org/10.1016/j.fmre.2024.05.018